Aminologics Co.,Ltd. (KOSDAQ:074430)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,021.00
+6.00 (0.59%)
At close: Aug 7, 2026

Aminologics Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
22,67622,02016,79020,88727,33722,849
Revenue Growth
36.76%31.15%-19.61%-23.60%19.64%29.45%
Gross Profit
10,2069,8323,3847,73412,7909,128
Operating Income
3,7123,594-2,1531,4626,9083,953
Net Income
2,2593,522-1,6202,436-7,2825,360
Earnings Per Share
25.6140.10-18.0027.74-82.9161.03
EPS Growth
-----150.46%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
68,12563,03235,38228,49929,23825,663
Total Debt
16,64016,2142,0181,8191,9891,654
Net Cash (Debt)
51,48646,81733,36426,68027,24924,010
Net Cash Growth
40.29%40.32%25.05%-2.09%13.49%1.29%
Net Cash Per Share
583.68533.07370.70303.78310.26273.38

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
7,6282,5417,466-218.155,226935.52
Capital Expenditures
-75.7-45.7-511.5-155.8-490.2-515.71
Free Cash Flow
7,5522,4956,955-373.954,736419.81
Free Cash Flow Growth
493.24%-64.13%--1028.11%-71.24%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.01%44.65%20.16%37.03%46.79%39.95%
Operating Margin
16.37%16.32%-12.82%7.00%25.27%17.30%
Pretax Margin
10.23%15.96%-6.58%10.97%-22.98%16.21%
Profit Margin
9.96%15.99%-9.65%11.66%-26.64%23.46%
FCF Margin
33.30%11.33%41.42%-1.79%17.32%1.84%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
39.6429.78-48.45-35.97
P/FCF Ratio
11.8042.0311.34-33.94459.21
PS Ratio
3.934.764.705.655.888.44